平特五不中

Dr. Jonathan Spicer is an associate professor of surgery at 平特五不中, where he is the medical director of the 平特五不中 Health Center (MUHC) Thoracic Oncology Network. He chairs the 平特五不中 regional thoracic oncology tumor board and is co-director of the MUHC thoracic oncology clinical trials unit. Dr. Spicer is a surgeon scientist leading a broad research program covering basic, translational and clinical research topics. He trained in general surgery at 平特五不中 and subsequently in cardiothoracic surgery at the University of Texas, MD Anderson Cancer Centre. On a basic science front, Dr. Spicer is recognized as a leader in our understanding of how neutrophils impact cancer progression, and in particular, on the role of neutrophil extracellular traps in cancer biology. On a clinical front, Dr. Spicer has developed one of the most active research programs in the area of neoadjuvant immunotherapy for operable lung cancer. He is an expert in surgical enhanced recovery protocols and his clinical practice is focused on minimal access techniques for pulmonary surgery and extended resections for thoracic malignancies. He is the program director for the 平特五不中 Advanced Thoracic and Upper GI Surgical Oncology Fellowship. Dr. Spicer is the research chair for the Canadian Association of Thoracic Surgeons, director of the Canadian Cancer Trials Mesothelioma Working Group and sits on numerous steering committees for phase 2 and 3 international trials investigating the use of novel therapies prior to lung cancer resections.